Condition
To Evaluate the Efficiency of Apoptosis-associated Markers to Differentiate Potential of Active TB From LTBI
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Unknown1
Clinical Trials (1)
Showing 1 of 1 trials
NCT01676155Unknown
The Role of Apoptosis Associated Markers in Pathogenesis of Pulmonary Tuberculosis
Showing all 1 trials
Research Network
Active Sponsors
- National Taiwan University Hospital1
Top Investigators
National Taiwan University Hospital
Related Conditions
- To Compare The Serum Apoptosisassociated Markers Between Patients With Active Tb And Patients With Ltbi1